Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 200 Applications Received to Align Indications with Original Products
October 2, 2006
- Reducing Average Length of Hospital Stay Essential: Vice Minister
October 2, 2006
- Taiyo Pharm. Completes Seamless Production Line for Prefilled Syringes
October 2, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 2, 2006
- Wholesalers Must Offer Well-Grounded Prices: Korosho Hearing
October 2, 2006
- Novartis, Daiichi Sankyo to Terminate Agreement for Lamisil AT, Nicotinel TTS
October 2, 2006
- Inter-ministerial Efforts Accelerated to Promote Life Science
October 2, 2006
- SSP to Launch CHOLESTEGUARD to Fight High Cholesterol
October 2, 2006
- Barcode Labering Requirements Annouced
October 2, 2006
- Industry Seeks to Bring About Gov't-Industry Dialogue: JPMA Policy Seminar
October 2, 2006
- Pneumococcal Vaccination in the Elderly Needs Government Support
September 25, 2006
- Kowa Pharmaceutical Aims for Sales of \74.8 Bil. in FY2007
September 25, 2006
- R&D NEWS IN BRIEF
September 25, 2006
- Once-weekly Osteoporosis Drug Both Effective and Convenient
September 25, 2006
- Dr Bale Discusses Current Top Priorities at IFPMA
September 25, 2006
- Korosho to Promote Domestic Vaccine Development, Blood Donation
September 25, 2006
- Aging, Vitamin C Deficiency Contribute to COPD
September 25, 2006
- Global Partnerships Essential in BT Industry: Dr Mimura
September 25, 2006
- Online Processing of Medical Bills to Expand in April 2007
September 25, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
September 25, 2006
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…